Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin-treated cardiovascular disease: A 30-month randomized placebo-controlled trial.
Ninad V SalastekarTanvi DesaiThomas HauserErnst J SchaeferKristen FowlerStacey JosephSteven E ShoelsonAllison B Goldfinenull nullPublished in: Diabetes, obesity & metabolism (2017)
Salsalate improves glycemia in obese persons at increased risk for diabetes, and hence may decrease risk of incident type 2 diabetes. Salsalate may inform new therapeutic approaches for diabetes prevention, but renal safety may limit clinical utility.
Keyphrases